Announcements Trials
Browse Landscape

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 107Observational 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Primary Myelofibrosis 1Polycythemia Vera 1Bone Marrow Neoplasms 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × ruxolitinib × Clear all
NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting
90 enrolled
Myeloid

Bone Marrow Neoplasms, Primary Myelofibrosis

NCT05566535 2022-10-04

QoL-PV-R

Multinational Center for Quality of Life Research, Russia

Unknown
32 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡